Recent

% | $
Quotes you view appear here for quick access.

Antares Pharma Inc. Message Board

  • jrdelane jrdelane Feb 17, 2013 1:04 AM Flag

    The Golden Cross vs. the Death Cross

    Biotech stocks are driven by news catalysts--trial updates, FDA announcements, earnings reports, new finance offerings, partnerships, buyouts, etc. how big a role do technicals play then, when your biotech stock is about to experience a very significant chart event? I own shares of two very good biotechs that have these significant Cross events right now. APPY just experienced a golden cross on Wednesday, where the 50-day MA crossed up and over the 200-day moving average. Friday a new up leg appears to have begun. ATRS on the other hand, is poised to experience a Death Cross early next week IF there is further weakness in the stock. Look at the chart, verify this for yourself. I don't want this to happen, I own 12,000 shares, but we need some positive PR on Monday or I fear the black boxes in the trading rooms are going to unleash a fury of selling pressure on all us faithful longs. My Refuse to Lose post perhaps should read Refuse to Lose More! I am going to decide Monday if I stay or leave depending on price action and/or news. I hesitated to post this at all because it has bearish implications. But for some, it could be a prudent and timely warning to prevent further carnage. GLTA!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ATRS
1.020.00(0.00%)1:27 PMEDT